Inhibition of Deamination of Arabinosylcytosine (NSC-63878) by Rhodium (II) Acetate
Lee, S.H.; Chao, D.L.; Bear, J.L.; Kimball, A.P.
Cancer ChemoTherapy Reports 59(3): 661-663
1975
ISSN/ISBN: 0069-0112 PMID: 1203890 Document Number: 88352
The nobel metal "cage" complex, rhodium(II) acetate, was found to inhibit the deamination of the fraudulent nucleoside, arabinosylcytosine. Potent inhibition of a purified cytidine deaminase from mouse kidney was observed when either cytidine or arabinosylcytosine was used as substrate.
Document emailed within 1 workday
Related Documents
Chao, D.L.; Kimball, A.P. 1972: Deamination of arabinosyladenine by adenosine deaminase and inhibition by arabinosyl-6-mercaptopurine Cancer Research 32(8): 1721-1724Deverina, I.S. 1980: Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver Biokhimiia 45(10): 1897-1908
LePage, G.A.; White, S.C. 1973: Scheduling of arabinosylcytosine and 6-thioguanine therapy Cancer Research 33(5): 946-949
Melo, J.F.; Coutinho, E.M. 1977: Inhibition of spermatogenesis in men with monthly injections of medroxyprogesterone acetate and testosterone enanthate Contraception 15(6): 627-634
Velikii, N.N.; Mogilevich, S.E.; Simonova, N.I. 1978: Nicotinamide inhibition of 2-14C acetate incorporation into free fatty acids and lipids of rat tissues Ukrainskii Biokhimicheskii Zhurnal 50(3): 368-371
Schmitz, O.; Hansen, A.P.; Hansen, H.E.; Orskov, H. 1982: Inhibition of arginine- and hypoglycemia- induced growth hormone release by acetate in dialyzed patients Clinical Nephrology 17(2): 70-76
Bear, J.L.; Gray, H.B.; Rainen, L.; Chang, I.M.; Howard, R.; Serio, G.; Kimball, A.P. 1975: Interaction of Rhodium(II) carboxylates with molecules of biologic importance Cancer ChemoTherapy Reports 59(3): 611-620
Barranco, S.C.; Ho, D.H.; Drewinko, B.; Romsdahl, M.M.; Humphrey, R.M. 1972: Differential sensitivites of human melanoma cells grown in vitro to arabinosylcytosine Cancer Research 32(12): 2733-2736
Verbin, R.S.; Diluiso, G.; Farber, E. 1973: Protective effects of cycloheximide against 1-beta-D-arabinosylcytosine-induced intestinal lesions Cancer Research 33(9): 2086-2093
Thompson, H.J.; Becci, P.J.; Brown, C.C.; Moon, R.C. 1979: Effect of the duration of retinyl acetate feeding on inhibition of 1-methyl-1-nitrosourea-induced mammary carcinogenesis in the rat Cancer Research 39(10): 3977-3980
Adachi, S.; Tsujimura, T.; Jippo, T.; Morimoto, M.; Isozaki, K.; Kasugai, T.; Nomura, S.; Kitamura, Y. 1995: Inhibition of attachment between cultured mast cells and fibroblasts by phorbol 12-myristate 13-acetate and stem cell factor Experimental Hematology 23(1): 58-65
Weekes, R.G.; Verma, A.K.; Boutwell, R.K. 1980: Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate Cancer Research 40(11): 4013-4018
Rembish, S.J.; Yang, Y.; Trush, M.A. 1994: Inhibition of mitochondrial superoxide generation in rat alveolar macrophages by 12-O-tetradecanoylphorbol-13-acetate: potential role of protein kinase C Research Communications in Molecular Pathology and Pharmacology 85(2): 115-129
Lee, M.J.; Hsu, J.D.; Wang, C.J. 1995: Inhibition of 12-O-tetradecanoylphorbol-13-acetate-caused tumor promotion in benzo[a]pyrene-initiated CD-1 mouse skin by geniposide Anticancer Research 15(2): 411-416
Sülü, M.; Küçükbay, H.; Durmaz, R.; Günal, S. 2000: Antifungal activity of rhodium, iridium, and ruthenium tripodal phosphine complexes New Microbiologica 23(1): 73-78
Poirier, L.A.; Theiss, J.C.; Arnold, L.J.; Shimkin, M.B. 1984: Inhibition by magnesium and calcium acetates of lead subacetate- and nickel acetate-induced lung tumors in strain a mice Cancer Research 44(4): 1520-1522
Bruevich, T.S.; Bogomolets, N.N.; Berezovskiĭ, A.D. 1980: Sensitizing action of precious metal compounds: gold, platinum, ruthenium, rhodium and silver Gigiena Truda i Professional'nye Zabolevaniya (5): 42-44
Sturm, G.; Antal, E.; Schmidt Rhode, P.; Bauer, T.; Schulz K D. 1986: Medroxyprogesterone acetate and immunoreactive medroxyprogesterone acetate metabolites measured by two different selective radioimmunoassay antibodies in medroxyprogesterone acetate treated breast cancer patients Anticancer Research 6(3 Part A): 362
Rao, P.N.; Smith, M.L.; Pathak, S.; Howard, R.A.; Bear, J.L. 1980: Rhodium (II) butyrate: a potential anticancer drug with cell cycle phase-specific effects in HeLa cells Journal of the National Cancer Institute 64(4): 905-912
Nakadate, T.; Yamamoto, S.; Aizu, E.; Kato, R. 1984: Effects of flavonoids and antioxidants on 12-O-tetradecanoyl-phorbol-13-acetate-caused epidermal ornithine decarboxylase induction and tumor promotion in relation to lipoxygenase inhibition by these compounds Gan 75(3): 214-222